Journey Medical Corporation (DERM) Investor Relations Documents

Journey Medical Corporation (DERM) investor relations documents from the company's IR site: 2 presentations, 32 press releases; latest deck 2026-07-01. Read in-app with summaries. First-party data.

Journey Medical Corporate Overview: Journey Medical (NASDAQ: DERM) is a commercial-stage dermatology company with a $195M market cap, anchored by the 2025 launch of its flagship product, Emrosi.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-12Press releaseJourney Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
2026-08-05Press releaseJourney Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026
2026-07-01PresentationJourney Medical Corporate Overview
2026-05-19Press releaseJourney Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference
2026-05-19Press releaseDownload as PDF
2026-05-13Press releaseJourney Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
2026-05-13Press releasePDF
2026-05-06Press releaseJourney Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026
2026-05-06Press releaseDownload as PDF
2026-05-05PresentationJourney Medical Corporate Overview
2026-04-21Press releaseJourney Medical Corporation Secures Contract with Third Major GPO for Emrosi™
2026-04-21Press releaseDownload as PDF
2026-03-25Press releaseJourney Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
2026-03-18Press releaseJourney Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026
2025-12-10Press releaseJourney Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on
2025-11-12Press releaseJourney Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
2025-11-05Press releaseJourney Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025
2025-10-08Press releaseJourney Medical Corporation to Participate in October 2025 Investor Conferences
2025-09-03Press releaseJourney Medical Corporation to Participate in September 2025 Investor Conferences
Press releaseJourney Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
2025-08-05Press releaseJourney Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025
2025-05-07Press releaseJourney Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025
2025-03-26Press releaseJourney Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
2025-03-19Press releaseJourney Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025
2024-08-12Press releaseJourney Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
2024-08-06Press releaseJourney Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024
2024-05-07Press releaseJourney Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024
2023-08-08Press releaseJourney Medical Corporation Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
2022-11-03Press releaseJourney Medical Corporation to Announce Third Quarter 2022 Financial Results on November 10, 2022
2022-08-03Press releaseJourney Medical Corporation to Announce Second Quarter 2022 Financial Results on August 9, 2022
2022-05-10Press releaseJourney Medical Corporation Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
2022-05-03Press releaseJourney Medical Corporation to Announce First Quarter 2022 Financial Results on May 10, 2022
2022-04-04Press releaseJourney Medical Corporation to Present at the Virtual Fortress Biotech R&D Summit Hosted by B. Riley Securities
2021-12-10Press releaseJourney Medical Corporation Reports Third Quarter 2021 Financial Results and Recent Corporate Highlights

DERM overview · DERM earnings · DERM financials · DERM KPIs · DERM ownership · DERM peers · DERM filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.